About Fortron Bio Science
Fortron Bio Science is a company based in Morrisville (United States) founded in 1997 was acquired by R&D Systems in July 2005. Fortron Bio Science operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter Morrisville, United States
- SectorsHealthcare
- Website fortron.com
- Acquired by R&D Systems (Jul 2005)
- Investors
- Acquired byR&D Systems
(Jul 2005)
Investors in Fortron Bio Science
Fortron Bio Science has secured backing from 1 investor. Prominent investors backing the company include R&D Systems.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Reagents and kits are developed for biotech research applications. | 1985 | rndsystems.com | Minneapolis, United States |
Investor details for Fortron Bio Science
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Fortron Bio Science
2 dated milestones of Fortron Bio Science across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Fortron Bio Science is founded.
- Exit Acquired by R&D Systems.
Competitors of Fortron Bio Science
Fortron Bio Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | – | Monoclonal antibody technology and products are developed by Epitomics. | |
| ybiologics.com | 2007 | Daejeon, South Korea | $42.1M | – | Developer of antibodies for the treatment of multiple diseases | |
| mabtech.com | 1986 | Nacka, Sweden | – | – | Antibodies and immunoassay kits are developed for research applications. | |
| opmbiosciences.com | 2013 | Pudong, China | $14.42M | – | Antibody and vaccine culture media products are developed. | |
| itb-med.com | 2016 | Stockholm, Sweden | $87M | – | Monoclonal antibodies are developed to prevent transplant rejections. | |
| abrevbio.com | 2018 | Nanjing, China | $90M | – | Antibody-drug development platforms are provided for life sciences research. | |
| vectorlabs.com | 1976 | Burlingame, United States | – | – | Labeling and detection reagents immunohistochemistry studies and other life science research applications | |
| allelebiotech.com | 1999 | San Diego, United States | $18M | – | Nano-antibodies, iPSCs, fluorescent proteins, and RNAi are developed. |
Detailed competitors of Fortron Bio Science
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Fortron Bio Science
10 companies that operate in the same segment as Fortron Bio Science (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Fortron Bio Science
Fortron Bio Science was founded in 1997.
Fortron Bio Science is headquartered in Morrisville, United States.
Fortron Bio Science was founded in 1997 and is based in Morrisville, United States. Antibody and antigen reagents are purified and supplied to in-vitro diagnostics, pharmaceutical, and biotechnology firms. Antibody diagnostics kits and immunoassay kits are provided, with production occurring in USDA-licensed facilities to support research and development needs in the sector.
Fortron Bio Science's top competitors include Sino Biological, GenScript and Y-Biologics.
Fortron Bio Science has 1 investor. Key investors include R&D Systems.
Yes. Fortron Bio Science was acquired by R&D Systems in July 2005.